Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Myojin

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Gastroenterology|December 23, 2025
Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseasesYuta Myojin, Hayato Hikita
Immunological Medicine|June 2, 2026
Immune checkpoint inhibitor-associated hepatitis and colitis: current understanding and clinical approachesYuta Myojin, Takahiro Kodama
Cancer Journal (Sudbury, Mass.)|March 23, 2023
The Microbiome and Liver CancerYuta Myojin, Tim F Greten
Cancers|September 22, 2019
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular CarcinomaShigeki Suemura, Takahiro Kodama, Yuta Myojin, et al.
JHEP Reports : Innovation in Hepatology|May 9, 2025
Hepatic immune environment differences among common mouse strains in models of MASH and liver cancerPatrick Huang, Francisco J Rodriguez-Matos, Jonathan Qi, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Hepatology Communications|January 21, 2026
Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLDYuta Myojin, Takahiro Kodama, Ryo Takahashi, et al.
Plos One|July 2, 2020
Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levelsKatsuhiko Sato, Hayato Hikita, Yuta Myojin, et al.
Scientific Reports|February 10, 2021
Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regenerationYasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, et al.
Hepatology Communications|September 29, 2021
Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse LiverMakiko Urabe, Hayato Hikita, Yoshinobu Saito, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Gastroenterology|December 23, 2025
Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseasesYuta Myojin, Hayato Hikita
Immunological Medicine|June 2, 2026
Immune checkpoint inhibitor-associated hepatitis and colitis: current understanding and clinical approachesYuta Myojin, Takahiro Kodama
Cancer Journal (Sudbury, Mass.)|March 23, 2023
The Microbiome and Liver CancerYuta Myojin, Tim F Greten
Cancers|September 22, 2019
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular CarcinomaShigeki Suemura, Takahiro Kodama, Yuta Myojin, et al.
JHEP Reports : Innovation in Hepatology|May 9, 2025
Hepatic immune environment differences among common mouse strains in models of MASH and liver cancerPatrick Huang, Francisco J Rodriguez-Matos, Jonathan Qi, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Hepatology Communications|January 21, 2026
Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLDYuta Myojin, Takahiro Kodama, Ryo Takahashi, et al.
Plos One|July 2, 2020
Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levelsKatsuhiko Sato, Hayato Hikita, Yuta Myojin, et al.
Scientific Reports|February 10, 2021
Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regenerationYasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, et al.
Hepatology Communications|September 29, 2021
Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse LiverMakiko Urabe, Hayato Hikita, Yoshinobu Saito, et al.
Pageof 4